drugset / Trial / NCT02080715

Role of the Catechol-O-methyltransferase (COMT) in the Physiological Regulation of Vigilance

NCT02080715

Phase 1 Completed 30 enrolled University of Zurich
NaSingle-groupDouble-blindTreatment

Summary

In this study, pharmacologic effects of COMT inhibition during sleep deprivation in healthy subjects in dependence of their Val158Met genotype of COMT are studied. Potential effects are identified by measurement of vigilance and cognitive performance as well as EEG measurements during wake and sleep. * Trial with medicinal product

Timeline

Start
2013-06
Primary completion
2014-04
Completion
2014-04

Drugs

EvaluationDrugModalityDoseRoute
Subject Tolcapone Unknown 100 mg

Indications

No indication recorded.